The United States Food and Drug Administration (USFDA) approves Zydus Lifescience for Empagliflozin and Metformin Hydrochloride Tablets in 5 mg/500 mg, 5 mg/1000 mg, 12.5 mg/500 mg, and 12.5 mg/1000 mg.

• Defence Ministry Signs Rs 661.5 Cr BrahMos Navy Contract
• Hester Biosciences Approves Rs 1.05 Cr Solar Power Investment
• Mphasis Signs £35.4 Million Deal With Social Security Scotland
• Solex Energy Bags Rs 76 Cr Solar Module Order
• Interarch Climbs 2% on Rs 61 Cr Copper Refinery Order

These tablets are used for proper diet and exercise, which improves glycemic control in adults with two types of diabetes mellitus.

Also, they are used to lower the risk of cardiovascular disease. In India, only Ahmedabad will be manufactured at the formulation facility at SEZ.